← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

PYPD logoPolyPid Ltd.(PYPD)Earnings, Financials & Key Ratios

PYPD•NASDAQ
$4.44
$81M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryDrug Delivery Technology Platforms
AboutPolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.Show more
  • Revenue$0
  • EBITDA-$31M-18.7%
  • Net Income-$34M-17.7%
  • EPS (Diluted)-2.09+57.4%
  • ROE-366.29%+64.7%
  • ROIC-547.81%+25.3%
  • Debt/Equity0.25-79.6%
Technical→

PYPD Key Insights

PolyPid Ltd. (PYPD) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Shares diluted 100.0% in last year
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PYPD Price & Volume

PolyPid Ltd. (PYPD) stock price & volume — 10-year historical chart

Loading chart...

PYPD Growth Metrics

PolyPid Ltd. (PYPD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-43.18%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM91.97%

Return on Capital

10 Years-136.43%
5 Years-183.72%
3 Years-231.45%
Last Year-243.24%

PYPD Peer Comparison

PolyPid Ltd. (PYPD) competitors in Drug Delivery Technology Platforms — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
AGIO logoAGIOAgios Pharmaceuticals, Inc.Direct Competitor1.64B27.53-3.8748.03%-6.4%-34.11%0.05
ACRS logoACRSAclaris Therapeutics, Inc.Direct Competitor585.63M4.86-9.17-58.19%-8.3%-62.98%
HALO logoHALOHalozyme Therapeutics, Inc.Direct Competitor7.68B65.1925.4637.55%22.69%6.49%
CLDX logoCLDXCelldex Therapeutics, Inc.Product Competitor2.22B33.32-8.54-78.63%-172.53%-41.68%0.00
NKTR logoNKTRNektar TherapeuticsProduct Competitor1.69B83.37-8.57-43.89%-297.07%-399.1%1.66
MRK logoMRKMerck & Co., Inc.Supply Chain277.34B112.2915.421.18%28.12%36.14%0.96
PFE logoPFEPfizer Inc.Supply Chain150.63B26.4819.47-1.65%11.83%8.34%0.78
BMY logoBMYBristol-Myers Squibb CompanySupply Chain114.85B56.2516.30-0.22%15.01%38.96%2.55

Compare PYPD vs Peers

PolyPid Ltd. (PYPD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AGIO

Most directly comparable listed peer for PYPD.

Scale Benchmark

vs ABBV

Larger-name benchmark to compare PYPD against a more recognizable public peer.

Peer Set

Compare Top 5

vs AGIO, ACRS, HALO, CLDX

PYPD Income Statement

PolyPid Ltd. (PYPD) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue000000000
Revenue Growth %---------
Cost of Goods Sold205K411K947K1.01M1.12M1.72M000
COGS % of Revenue---------
Gross Profit
-205K▲ 0%
-411K▼ 100.5%
-947K▼ 130.4%
-1.01M▼ 6.9%
-1.12M▼ 10.5%
-1.72M▼ 53.9%
0▲ 100.0%
0▲ 0%
0▲ 0%
Gross Margin %---------
Gross Profit Growth %-61.42%-100.49%-130.41%-6.86%-10.47%-53.94%100%--
Operating Expenses13.8M18.36M17.61M25.26M42.03M37.17M22.87M28.03M32.97M
OpEx % of Revenue---------
Selling, General & Admin4.06M5.81M3.53M9.32M12.45M10.9M6.72M5.22M9.16M
SG&A % of Revenue---------
Research & Development9.74M12.55M14.08M16.95M30.42M27.99M16.15M22.81M23.81M
R&D % of Revenue---------
Other Operating Expenses000-1.01M-848K-1.72M000
Operating Income
-13.8M▲ 0%
-18.36M▼ 33.1%
-18.56M▼ 1.1%
-26.27M▼ 41.6%
-43.15M▼ 64.2%
-38.89M▲ 9.9%
-22.87M▲ 41.2%
-28.03M▼ 22.6%
-32.97M▼ 17.6%
Operating Margin %---------
Operating Income Growth %-34.52%-33.07%-1.07%-41.55%-64.22%9.87%41.2%-22.57%-17.62%
EBITDA-13.6M-17.95M-17.61M-25.26M-42.03M-37.17M-21.05M-26.41M-31.34M
EBITDA Margin %---------
EBITDA Growth %-34.18%-32.06%1.89%-43.42%-66.38%11.56%43.38%-25.48%-18.7%
D&A (Non-Cash Add-back)205K411K947K1.01M1.12M1.72M1.82M1.62M1.62M
EBIT-54.47M5.96M-6.89M-36.87M-42.6M-38.09M-22.87M-28.03M-32.97M
Net Interest Income74K84K45K457K468K-1.07M-1.16M-1.08M-685K
Interest Income90K126K60K474K468K267K548K442K0
Interest Expense16K42K15K17K01.34M1.71M1.52M0
Other Income/Expense-40.69M24.28M11.65M-10.6M544K-540K-929K-951K-1.2M
Pretax Income
-54.49M▲ 0%
5.92M▲ 110.9%
-6.91M▼ 216.7%
-36.87M▼ 433.9%
-42.6M▼ 15.5%
-39.43M▲ 7.4%
-23.8M▲ 39.6%
-28.98M▼ 21.8%
-34.16M▼ 17.9%
Pretax Margin %---------
Income Tax00000129K69K42K5K
Effective Tax Rate %0%0%0%0%0%-0.33%-0.29%-0.14%-0.01%
Net Income
-54.49M▲ 0%
5.92M▲ 110.9%
-6.91M▼ 216.7%
-35.32M▼ 411.6%
-40.71M▼ 15.3%
-39.52M▲ 2.9%
-23.86M▲ 39.6%
-29.02M▼ 21.6%
-34.17M▼ 17.7%
Net Margin %---------
Net Income Growth %-378.3%110.86%-216.7%-411.57%-15.26%2.92%39.62%-21.61%-17.73%
Net Income (Continuing)-54.49M5.92M-6.91M-36.87M-42.6M-39.56M-23.86M-29.02M-34.17M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)
-370.58▲ 0%
26.70▲ 107.2%
21.44▼ 19.7%
-122.10▼ 669.5%
-67.80▲ 44.5%
-61.20▲ 9.7%
-16.99▲ 72.2%
-4.91▲ 71.1%
-2.09▲ 57.4%
EPS Growth %-378.29%107.2%-19.7%-669.5%44.47%9.73%72.24%71.1%57.43%
EPS (Basic)-370.5826.7021.44-4.48-67.80-61.20-16.99-4.91-2.09
Diluted Shares Outstanding588.15K886.43K886.43K1.28M1.25M1.3M1.4M5.91M16.35M
Basic Shares Outstanding588.15K886.43K886.43K1.28M1.25M1.3M1.4M5.91M16.35M
Dividend Payout Ratio---------

PYPD Balance Sheet

PolyPid Ltd. (PYPD) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets18.73M8.03M27.41M47.2M34.81M14.19M6.07M16.57M15.23M
Cash & Short-Term Investments17.94M7.33M26.62M44.48M32.2M12.59M5.61M15.64M12.93M
Cash Only3.91M7.33M3.94M4.32M9.82M8.55M5.61M15.64M6.4M
Short-Term Investments14.03M022.68M40.16M22.38M4.04M006.53M
Accounts Receivable28K24K18K139K118K298K000
Days Sales Outstanding---------
Inventory0-24K351K000001.11M
Days Inventory Outstanding--135.29------
Other Current Assets459K211K243K673K993K750K106K602K193K
Total Non-Current Assets4.25M6.45M6.35M28.65M9.42M11.78M9.3M8.65M7.08M
Property, Plant & Equipment2.93M6.19M6.12M5.89M8.76M11.68M9.22M8.37M6.77M
Fixed Asset Turnover---------
Goodwill000000000
Intangible Assets000000000
Long-Term Investments0219K199K000000
Other Non-Current Assets1.33M42K31K22.76M663K99K87K277K311K
Total Assets
22.98M▲ 0%
14.48M▼ 37.0%
33.77M▲ 133.1%
75.85M▲ 124.6%
44.23M▼ 41.7%
25.97M▼ 41.3%
15.37M▼ 40.8%
25.22M▲ 64.1%
22.31M▼ 11.6%
Asset Turnover---------
Asset Growth %19.48%-36.98%133.12%124.63%-41.68%-41.29%-40.81%64.06%-11.55%
Total Current Liabilities3.36M3.69M2.58M2.88M8.08M8.55M7.29M12.68M7.74M
Accounts Payable2.02M1.13M1.58M974K4.14M1.14M772K2.41M2.86M
Days Payables Outstanding3.59K1.01K609.36351.291.35K241.99---
Short-Term Debt000004.02M4M6.79M988K
Deferred Revenue (Current)000241K269K0000
Other Current Liabilities01.65M319K0016K1.01M23K0
Current Ratio5.57x2.18x10.63x16.41x4.31x1.66x0.83x1.31x1.97x
Quick Ratio5.57x2.18x10.49x16.41x4.31x1.66x0.83x1.31x1.82x
Cash Conversion Cycle---------
Total Non-Current Liabilities108.27M92.5M251K193K199K11.59M10.18M4.86M3.6M
Long-Term Debt000007.57M6.38M634K0
Capital Lease Obligations000001.17M857K1.28M647K
Deferred Tax Liabilities000000000
Other Non-Current Liabilities107.67M92.5M251K193K199K294K398K396K2.95M
Total Liabilities111.63M96.19M2.83M3.07M8.28M20.14M17.47M17.54M11.33M
Total Debt0000013.73M11.78M9.62M2.8M
Net Debt-3.91M-7.33M-3.94M-4.32M-9.82M5.18M6.17M-6.02M-3.61M
Debt / Equity-----2.36x-1.25x0.25x
Debt / EBITDA---------
Net Debt / EBITDA---------
Interest Coverage-862.50x-437.24x-1237.33x-1545.41x--29.04x-13.36x-18.38x-
Total Equity
-88.65M▲ 0%
-81.71M▲ 7.8%
30.93M▲ 137.9%
72.78M▲ 135.3%
35.96M▼ 50.6%
5.83M▼ 83.8%
-2.1M▼ 136.0%
7.68M▲ 466.6%
10.97M▲ 42.8%
Equity Growth %-161.04%7.82%137.86%135.26%-50.59%-83.79%-135.96%466.6%42.8%
Book Value per Share-150.72-92.1834.9056.9628.814.50-1.491.300.67
Total Shareholders' Equity-88.65M-81.71M30.93M72.78M35.96M5.83M-2.1M7.68M10.97M
Common Stock129K130K130K000000
Retained Earnings-92.31M-86.4M-93.3M-132.29M-174.89M-214.44M-238.31M-267.33M-301.5M
Treasury Stock-3.54M00000000
Accumulated OCI-766K-1.18M-2.12M000000
Minority Interest000000000

PYPD Cash Flow Statement

PolyPid Ltd. (PYPD) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-12.31M-16.68M-17.36M-21.6M-32.39M-34.32M-17.24M-21.96M0
Operating CF Margin %---------
Operating CF Growth %-26.5%-35.46%-4.08%-24.42%-49.96%-5.96%49.77%-27.43%100%
Net Income-54.49M5.92M-6.91M-36.87M-42.6M-39.56M-23.86M-29.02M-34.17M
Depreciation & Amortization205K411K947K1.01M1.12M1.72M1.82M1.62M0
Stock-Based Compensation1.38M995K976K4.58M4.75M4.31M3.39M2.82M0
Deferred Taxes0000-4.64M0-201K00
Other Non-Cash Items40.78M-24.47M-11.37M11.37M4.64M289K1.73M697K34.17M
Working Capital Changes-187K472K-1.01M-1.69M4.35M-1.08M-110K1.92M0
Change in Receivables000-1.92M123K0000
Change in Inventory0001.92M-123K0000
Change in Payables385K-887K449K-607K2.22M-3.1M-369K1.64M0
Cash from Investing-8.38M10.96M-23.56M-40.77M36.9M16.57M3.8M-330K0
Capital Expenditures-1.88M-3.07M-879K-1.18M-2.99M-1.77M-196K-76K0
CapEx % of Revenue---------
Acquisitions000000000
Investments---------
Other Investing-6.5M14.03M008M7M000
Cash from Financing14.38M9.39M37.65M62.77M1.03M16.43M9.98M32.42M0
Debt Issued (Net)0000011.31M-2.62M-3.32M0
Equity Issued (Net)1000K1000K1000K1000K1000K1000K1000K1000K0
Dividends Paid000000000
Share Repurchases000000000
Other Financing68K24K7K17K0696K3.87M-125K0
Net Change in Cash
-6.31M▲ 0%
3.67M▲ 158.1%
-3.27M▼ 189.1%
410K▲ 112.5%
5.55M▲ 1253.2%
-1.31M▼ 123.7%
-3.46M▼ 163.0%
10.12M▲ 392.9%
-15.81M▼ 256.2%
Free Cash Flow
-14.2M▲ 0%
-19.75M▼ 39.1%
-18.24M▲ 7.7%
-22.77M▼ 24.9%
-35.38M▼ 55.4%
-36.08M▼ 2.0%
-17.43M▲ 51.7%
-22.04M▼ 26.4%
0▲ 100.0%
FCF Margin %---------
FCF Growth %-38.2%-39.14%7.67%-24.87%-55.36%-1.99%51.69%-26.43%100%
FCF per Share-24.14-22.28-20.57-17.82-28.35-27.86-12.41-3.73-
FCF Conversion (FCF/Net Income)0.23x-2.82x2.51x0.61x0.80x0.87x0.72x0.76x-
Interest Paid00000734K1.04M950K0
Taxes Paid000008K18K3K0

PYPD Key Ratios

PolyPid Ltd. (PYPD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)----22.32%-68.12%-74.88%-189.16%-1278.6%-1038.73%-366.29%
Return on Invested Capital (ROIC)-----41.28%-68.41%-157.03%-227.44%-733.23%-547.81%
Debt / Equity------2.36x-1.25x0.25x
Interest Coverage-94.99x-862.50x-437.24x-1237.33x-1545.41x--29.04x-13.36x-18.38x-
FCF Conversion0.85x0.23x-2.82x2.51x0.61x0.80x0.87x0.72x0.76x-

PYPD Frequently Asked Questions

PolyPid Ltd. (PYPD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

PolyPid Ltd. (PYPD) grew revenue by 0.0% over the past year. Growth has been modest.

PolyPid Ltd. (PYPD) reported a net loss of $34.2M for fiscal year 2025.

Dividend & Returns

PolyPid Ltd. (PYPD) has a return on equity (ROE) of -366.3%. Negative ROE indicates the company is unprofitable.

Explore More PYPD

PolyPid Ltd. (PYPD) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.